Curie

Rocket Lab Prepares to Launch Mission for KAIST and NASA to Deploy Satellites to Two Separate Orbits

Retrieved on: 
Monday, April 1, 2024
Other Transport, Technology, Transport, Satellite, Other Technology, Aerospace, Manufacturing, Other Science, Science, Neutron, Artificial intelligence, Wind, Spacecraft, ICT, Electron, Asteroid, Burns, Initiative, Varda, Lab, Curie, NASA, Sunlight, Rocket Lab, Ministry, Kick, MSIT, Security (finance), Annual report, Engineering, Pressure, Silicon, Moon, Satrec Initiative, Korea Aerospace Research Institute, Communications satellite

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has set the launch window for its next Electron launch.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has set the launch window for its next Electron launch.
  • The ‘Beginning Of The Swarm’ mission is scheduled to launch from Rocket Lab Launch Complex 1 in Mahia, New Zealand during a 14-day launch window that opens on April 24th.
  • The capability of Electron’s Kick Stage to perform multiple engine burns in space and deploy individual satellites to unique orbits is critical to this mission.
  • Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia.

New Report Ranks Regional Risk of Radon-Induced Lung Cancer; Reveals Dangerously Undertested Regions

Retrieved on: 
Thursday, January 25, 2024
Death, Curie, EPA, Person, Smoking, Radon, Blog, Lung cancer, Risk, CDC, Index, Data analysis, Diagnosis, Uranium mining

LOUISVILLE, Ky., Jan. 25, 2024 /PRNewswire-PRWeb/ -- Ranking regions by the known indoor radon results shows communities at higher risk for radon-induced lung cancer, highlighting the need for more awareness, increased testing, and inspiring improved risk reduction.

Key Points: 
  • "That's why we are providing this data analysis along with our interactive National Radon Risk Search™ tool to empower individuals and communities to take action and reduce their risk of radon-induced lung cancer."
  • To better understand radon risk in communities across the United States, use the Protect Environmental National Radon Risk Search™ tool.
  • To increase access to testing, Protect Environmental and the American Lung Association are partnering to provide no-cost professional radon testing for homeowners in high-risk regions.
  • To encourage more testing nationwide during National Radon Action Month , discounted do-it-yourself radon test kits are also available through January.

Protect Environmental Releases Inaugural National Radon Risk Index™

Retrieved on: 
Thursday, January 12, 2023
Smokers v Non-Smokers, EPA, Person, Lung cancer, Smoking, Risk, Work, Korea Disease Control and Prevention Agency, United States Environmental Protection Agency, Curie, Death, Radon, Index, Blog, CDC, Uranium

LOUISVILLE, Ky., Jan. 12, 2023 /PRNewswire-PRWeb/ -- In conjunction with the launch earlier this week of its interactive National Radon Risk Search™ tool, Protect Environmental announced today the release of its inaugural National Radon Risk Index™. The index pulls from the company's comprehensive database of radon test results, which represents more than 2.5 million data points compiled from sources, such as the Centers for Disease Control and Prevention (CDC), as well as Protect Environmental's own internal testing data, to rank communities across the United States according to their radon risk. The index, which will be updated and published each January in support of National Radon Action Month, ranks communities using the following data points: (1) highest radon level recorded in a building tested within the community; (2) average radon level of all buildings tested within the community; (3) percentage of buildings tested with a radon level above the Environmental Protection Agency's (EPA) action level of 4.0 pCi/L, within the community; and, (4) highest and lowest percentages of residential buildings characterized for radon risk within the community. The interactive search tool and index are designed to empower communities with vital information to understand the impact of radon in the places where community members live, work, and learn, as well as to assist policymakers with efforts to protect their communities from unsafe exposure to radioactive, cancer-causing radon.

Key Points: 
  • LOUISVILLE, Ky., Jan. 12, 2023 /PRNewswire-PRWeb/ -- In conjunction with the launch earlier this week of its interactive National Radon Risk Search™ tool, Protect Environmental announced today the release of its inaugural National Radon Risk Index™ .
  • The index, which will be updated and published each January in support of National Radon Action Month , ranks communities using the following data points: (1) highest radon level recorded in a building tested within the community; (2) average radon level of all buildings tested within the community; (3) percentage of buildings tested with a radon level above the Environmental Protection Agency's (EPA) action level of 4.0 pCi/L , within the community; and, (4) highest and lowest percentages of residential buildings characterized for radon risk within the community.
  • The National Radon Risk Index provides the following insights into radon risk within communities across the United States:
    Highest radon level recorded in a building tested within the community: 7,879.3 pCi/L (Dallas County, TX)
    Highest average radon level of all buildings tested within the community: 53.8 pCi/L (Hinsdale County, CO)
    Highest percentage of buildings tested within the community with a radon level above the EPA's action level of 4.0 pCi/L: 93.8% (Roosevelt County, MT)
    Highest percentage of residential buildings characterized for radon risk within the community: 10.974% (Johnson County, IA)
    Lowest percentage of residential buildings characterized for radon risk within the community: 0.003% (Hidalgo County, TX)
    The full rankings contained within the index are available on the company's blog, The Green Scene .
  • To better understand radon risk in communities across the United States, use the Protect Environmental National Radon Risk Search tool .

Protect Environmental Launches National Radon Risk Search Tool

Retrieved on: 
Wednesday, January 11, 2023
Lung cancer, Work, Death, EPA, Radon, CDC, Smoking, Korea Disease Control and Prevention Agency, Risk, Person, United States Environmental Protection Agency, Non-Smokers' Rights Association, Curie, Uranium

LOUISVILLE, Ky., Jan. 10, 2023 /PRNewswire-PRWeb/ -- In conjunction with the launch of its next generation online presence, Protect Environmental announced today the launch of its National Radon Risk Search™ tool. The interactive search tool pulls from the company's comprehensive database of radon test results, which includes more than 2.5 million results compiled from sources such as the Centers for Disease Control and Prevention (CDC), as well as Protect Environmental's own internal testing data, to provide the following radon risk information for communities across the United States: (1) highest radon level recorded in a building within the community; (2) average radon level of all buildings within the community; (3) percentage of buildings with a radon level above the Environmental Protection Agency's (EPA) action level of 4.0 pCi/L within the community; and, (4) percentage of buildings characterized for radon risk within the community. The interactive search tool is designed to empower communities with vital information to understand the impact of radon in the places where community members live, work, and learn.        

Key Points: 
  • LOUISVILLE, Ky., Jan. 10, 2023 /PRNewswire-PRWeb/ -- In conjunction with the launch of its next generation online presence, Protect Environmental announced today the launch of its National Radon Risk Search™ tool.
  • The interactive search tool pulls from the company's comprehensive database of radon test results, which includes more than 2.5 million results compiled from sources such as the Centers for Disease Control and Prevention (CDC), as well as Protect Environmental's own internal testing data, to provide the following radon risk information for communities across the United States: (1) highest radon level recorded in a building within the community; (2) average radon level of all buildings within the community; (3) percentage of buildings with a radon level above the Environmental Protection Agency's (EPA) action level of 4.0 pCi/L within the community; and, (4) percentage of buildings characterized for radon risk within the community.
  • The interactive search tool is designed to empower communities with vital information to understand the impact of radon in the places where community members live, work, and learn.
  • "Our interactive search tool makes understanding this risk much easier, which we hope will lead to more communities taking action to prevent this deadly disease."

Ring in the New Year by Reducing Your Risk of Exposure to Radioactive Cancer-Causing Gas

Retrieved on: 
Thursday, January 5, 2023
Lung cancer, Taste, EPA, Joint, Smoking, Smell, X-ray, Risk, Curie, ASTDR, Poison, Uranium, Radon

LOUISVILLE, Ky., Jan. 5, 2023 /PRNewswire-PRWeb/ -- This year more than 21,000 Americans will lose their battle to radon-induced lung cancer - that's one life lost every 25 minutes. January is designated as National Radon Action Month – a time to focus on protecting our communities and saving lives through preventing radon-induced lung cancer.

Key Points: 
  • Radon is a naturally occurring radioactive gas that rises from underground as Uranium decays.
  • It can enter buildings through joints or cracks in the foundation, water supply lines, or other entry points.
  • Exposure to radon can be deadly, as inhaling the radioactive particles can cause damage to the lungs.
  • The only way to know your risk of radon exposure is to test the places where you spend time indoors.

Movius Conversational AI to Power spocto’s Debt Support and Risk Mitigation Platform

Retrieved on: 
Monday, December 12, 2022
Software, Finance, Artificial Intelligence, Banking, Professional Services, Technology, Apps, Applications, Fintech, Cisco Systems, T-Mobile, BT Global Services, Machine learning, ML, Curie, CXO, Business, Telefónica, Reserve Bank of India, NPS, IBM, BlackBerry, Partnership, Communication, Entrepreneurship, ECL, Tech, Singtel, Credit, Intelligence, AI, NBFC and MFI in India, WhatsApp, Computacenter, Reserve Bank, Artificial intelligence, Multimedia, Education, Sequoia Capital, Chatbot, Silicon, Conversation, Risk, Medical device, Risk management, Bank, Hallam L. Movius, China Telecom

Movius, a global leader in cloud-based secure mobile communications, today announced that its conversational artificial intelligence (Conversational AI) platform, Curie, will power spoctos debt resolution and risk mitigation platform in India and the MENA region.

Key Points: 
  • Movius, a global leader in cloud-based secure mobile communications, today announced that its conversational artificial intelligence (Conversational AI) platform, Curie, will power spoctos debt resolution and risk mitigation platform in India and the MENA region.
  • We are very excited about this partnership with the worlds leading debt support and risk mitigation platform, spocto.
  • spoctos technology, riding on Moviuss conversational AI platform, helps ensure that the debt collection process is robust, personalized, and innovative, as the debt collection process becomes ethical.
  • spocto ( www.spocto.com ) is the world's leading debt support & risk mitigation platform focused on digitizing the entire collections processes for lenders.

FARFETCH and Outlier Ventures Announce First Cohort for Dream Assembly Base Camp

Retrieved on: 
Friday, October 21, 2022
Technology, Luxury, NFT, Professional Services, Metaverse, Fashion, Retail, Web3, Online Retail, U.S. Securities and Exchange Commission, Outlier, Commerce, Fantasy, SEC, Growth, E-commerce, Software as a service, NYSE, Annual report, 3D, Mentorship, NFT, Designing Economic Mechanisms, Program, Investment, New Guards Group, Partnership, Private Securities Litigation Reform Act, Curie, Assembly, Activision, Industry, Marketing, Ecosystem, Economics, WEAR, Product innovation, Environment, Digital, LVMH, Ubisoft, Solution, ESL, Fur clothing, Toy, Video game, 3D printing, Retail, Online shopping, Kering, Metaverse, Web3

FARFETCH Limited (NYSE: FTCH), the leading global platform for the luxury fashion industry, and Outlier Ventures, the leading global Web3 accelerator and investor, today announced the first cohort of start-ups for the Dream Assembly Base Camp accelerator program.

Key Points: 
  • FARFETCH Limited (NYSE: FTCH), the leading global platform for the luxury fashion industry, and Outlier Ventures, the leading global Web3 accelerator and investor, today announced the first cohort of start-ups for the Dream Assembly Base Camp accelerator program.
  • FARFETCH and Outlier Ventures are pleased to announce the eight new companies that will take part in the program.
  • Carol Hilsum, Senior Director of Product Innovation, FARFETCH, said:
    We are thrilled to welcome the first group of start-ups to our inaugural Dream Assembly Base Camp program.
  • Partnering with their Dream Assembly accelerator, Outlier Ventures brings its unparalleled deep knowledge and network to support start-ups to design, build and launch industry defining solutions with FARFETCH and its vast list of clients.

NorthStar Medical Radioisotopes and Curie Therapeutics Announce Priority Access Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

Retrieved on: 
Tuesday, June 7, 2022
Oncology, Medical Devices, Health, Radiology, Pharmaceutical, Biotechnology, Google Images, Leadership, Curie, Ligand, LLC, Degenerative disease, Cell death, Radionuclide, NorthStar, Therapy, Multimedia, FDA, Patient, Hospital, Waste management, CGMP, Radiation, Radiopharmaceutical, Drug Master File, Actinium-225, Cancer, Medical imaging, Pharmaceutical industry

NorthStar Medical Radioisotopes , LLC (NorthStar), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and Curie Therapeutics Inc., a therapeutics company dedicated to transforming cancer care with precision radiopharmaceuticals, today announced the signing of a long-term priority access supply agreement for the therapeutic medical radioisotope actinium-225 (Ac-225).

Key Points: 
  • NorthStar Medical Radioisotopes , LLC (NorthStar), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and Curie Therapeutics Inc., a therapeutics company dedicated to transforming cancer care with precision radiopharmaceuticals, today announced the signing of a long-term priority access supply agreement for the therapeutic medical radioisotope actinium-225 (Ac-225).
  • View the full release here: https://www.businesswire.com/news/home/20220607005136/en/
    Under the terms of the agreement, NorthStar will provide Curie Therapeutics with priority access to its electron accelerator-produced, n.c.a.
  • NorthStar is defining the supply chain for commercial-scale, reliable and environmentally preferred therapeutic radioisotope production.
  • NorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company that manufactures and distributes diagnostic and therapeutic radioisotopes and radiopharmaceuticals.

Varda Space Industries Orders Fourth Photon Spacecraft from Rocket Lab to Enable In-Space Manufacturing

Retrieved on: 
Tuesday, May 24, 2022
Satellite, Technology, Aerospace, Manufacturing, Other Technology, Software, Hardware, Neutron, Moon, Risk, Orbit, MDA, Private Securities Litigation Reform Act, U.S. Securities and Exchange Commission, CAPSTONE (spacecraft), IOT, Artemis, Environment, Government, Solution, Electron, Rocket Lab, COVID-19, Weightlessness, Mobile-satellite service, TSX, Spacecraft, Efficiency, Securities Act of 1933, Securities Exchange Act of 1934, Industry, Epidemic, Life, Partnership, Lists of disasters, Pandemic, Program, Curie, Technology, Lab, Maritime Transportation Security Act of 2002, Security (finance), SEC, NASA, GSAT, NYSE, Rocket Lab Photon, Transport, Synthetic rubber, Communications satellite, Mars, Rocket, Vala (Middle-earth), Photon

Rocket Lab (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, and Varda Space Industries (Varda), the worlds first In-space manufacturing and hypersonic Earth re-entry logistics company, today announced that Varda will procure a fourth Photon spacecraft.

Key Points: 
  • Rocket Lab (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, and Varda Space Industries (Varda), the worlds first In-space manufacturing and hypersonic Earth re-entry logistics company, today announced that Varda will procure a fourth Photon spacecraft.
  • The deal follows on a previous bulk-order by Varda in August 2021 for three Photon spacecraft from Rocket Lab.
  • Leveraging Rocket Labs vertically integrated capabilities as an end-to-end space company, each Photon will incorporate Rocket Lab star trackers, reaction wheels, solar panels, flight software, and radios.
  • "Rocket Labs Photon bus is a great compliment to Varda's in-space manufacturing and hypersonic re-entry logistics service," said Varda CEO Will Bruey.

Curie Therapeutics Expands Radiopharmaceutical Expertise with Appointment of Bernard Lambert, Ph.D. as Chief Technology Officer

Retrieved on: 
Monday, February 7, 2022
Biotechnology, Health, Radiology, Pharmaceutical, Oncology, NDA, Growth, Cancer, IND, Therapy, Leadership, Radiopharmaceutical, Brain, University, Radiochemistry, Chemistry, Prostate, Curie, Doctor of Philosophy, CMC, Medical imaging, Telix

Curie Therapeutics Inc. ("Curie"), a biotechnology company focused on developing innovative radiopharmaceutical therapies for oncological diseases, today announced the appointment of Bernard Lambert, Ph.D., as Chief Technology Officer.

Key Points: 
  • Curie Therapeutics Inc. ("Curie"), a biotechnology company focused on developing innovative radiopharmaceutical therapies for oncological diseases, today announced the appointment of Bernard Lambert, Ph.D., as Chief Technology Officer.
  • Dr. Lambert joins Curie Therapeutics to lead the Companys process development, manufacturing, and technical operations.
  • Curie is one of the few companies committed to this approach and I am delighted to be joining the leadership team.
  • Bernard is recognized as a leading figure in the development of therapeutic and companion diagnostic radiopharmaceutical molecules.